Zaheer Ali has a diverse work experience in the field of research and pharmaceuticals. Zaheer started their career as a Research Assistant and completed their Master's thesis project, where they developed methods to manipulate signaling pathways in zebrafish for angiogenesis research. Zaheer also gained proficiency in various scientific techniques during this time.
Zaheer then joined Linköping University as a Ph.D. Research Scholar and focused on investigating mechanisms of angiogenesis using zebrafish as an in-vivo model. Zaheer successfully developed a novel zebrafish-based model for studying angiogenesis and published 8 research articles. After completing their Ph.D., they continued working at Linköping University as a Research Engineer/Post-Doctoral Researcher. Here, they developed novel methods for visualizing zebrafish choriocapillaris and identified a novel transcriptional target for melanoma research.
In 2019, Zaheer briefly worked as a Pharmacist at Pharmacia and later joined BioReperia. At BioReperia, they initially served as a Product Specialist, responsible for utilizing the zebrafish technology platform to evaluate the efficacy and toxicity of anti-cancer therapeutics. Zaheer then progressed to the role of Project Manager, where they likely continued overseeing projects related to drug development.
Zaheer also had a short stint as a Specialty associate at Novartis in 2009.
Overall, Zaheer Ali's work experience is focused on research, particularly using zebrafish models, and their expertise lies in the fields of angiogenesis and pharmaceutical development.
Zaheer Ali's education history begins in 2001 when they attended the University of Malakand. Zaheer completed their Bachelor of Pharmacy degree in Pharmacy in 2007. In 2009, they enrolled at Linköping University and completed a Master's degree in Public Health in 2013. During the same period, they also obtained a Master's degree in Vascular Biology from the same university. From 2014 to 2018, Zaheer Ali pursued a Doctor of Philosophy - PhD at Linköping University, specializing in Vascular Biology and Oncology.